| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 5, 2025 | Spero Therapeutics, Inc. | CEO | Sell | 95.0 | +596,074 | 52.25% | ✗ | $121.2K |
| Aug 27, 2024 | Aug 29, 2024 | Spero Therapeutics, Inc. | CEO | Sell | 52.5 | -2,757 | -0.24% | ✗ | $3.7K |
| Aug 2, 2024 | Aug 6, 2024 | Spero Therapeutics, Inc. | CEO | Sell | 46.3 | -32,441 | -2.76% | ✗ | $42.6K |
| Feb 1, 2024 | Feb 5, 2024 | Spero Therapeutics, Inc. | CEO | Sell | 95.0 | +603,507 | 105.42% | ✓ | $107.7K |
| Aug 28, 2023 | Aug 30, 2023 | Spero Therapeutics, Inc. | CEO | Sell | 50.0 | -6,017 | -1.04% | ✓ | $7.7K |
| Feb 1, 2023 | Feb 3, 2023 | Spero Therapeutics, Inc. | CFO | Sell | 91.3 | +256,453 | 457.43% | ✓ | $17.4K |
| Aug 29, 2022 | Aug 30, 2022 | Spero Therapeutics, Inc. | CFO | Sell | 33.8 | -6,017 | -9.69% | ✓ | $5.4K |